BioTek reMEDys Adds UPLIZNA to its Specialty Therapeutics Portfolio

BioTek reMEDys manages the acquisition process for high end specialty pharmaceutical products. BioTek reMEDys provides critical benefits to all stakeholders on the treatment cycle – from patients and providers to payors and manufacturers – by managing the complex processes required to deliver and infuse biological therapies to patients battling chronic and severe disease states in the place of service best suited to each patient’s needs.

BioTek reMEDys offers aid and services that benefit all stakeholders in the treatment cycle. The company provides therapy-specific patient education materials and its National Customer Support Center is available 24 hours a day, 7 days a week to help patients manage critical aspects of their care.

A decade ago, BioTek reMEDys was launched with the mission to enhance pharmacy services for patients with neurological, immunological, hematological and other specialized diseases (such as hepatitis, MS and transplant patients) by concentrating on specific education, delivery and service needs tied to these conditions.

In addition to its focus on compassionate continuity of care for patients with life-altering diseases, BioTek reMEDys leverages supply chain management, cutting-edge technology and highly trained pharmacists to deliver superior service at affordable costs.

BioTek reMEDys announced the addition of UPLIZNA to its specialty therapeutics portfolio to provide treatment to a broader patient population and further expand upon its diverse pharmaceutical product offering.

By adding UPLIZNA to its extensive portfolio of life-saving specialty therapies, BioTek reMEDys is furthering its commitment to respond to the needs of and requests of patients and their loved ones.

UPLIZNA is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.

Effective immediately, UPLINZA will be available at all BioTek reMEDys locations.


Takeaway: BioTek reMEDys has become one of the nation’s largest independent infusion pharmacies focused on home infusion and infusion suites